Yeji

Upcoming catalysts

PDUFA target dates, FDA Advisory Committees, Phase 3 readouts, and approvals surfacing in the next 30 days.

All catalystsPDUFAAdComsReadoutsFDA decisions
30d90d180d365d

June 2026 · 2

PDUFAJun 24, 2026· in 18d
$ARWRArrowhead Pharmaceuticals, Inc.
Plozasiran · Familial Chylomicronemia Syndrome
“FDA accepted our New Drug Application for plozasiran with a PDUFA target action date of 2026-06-24.”
AdComJun 27, 2026· in 21d
$ALNYAlnylam Pharmaceuticals, Inc.
Vutrisiran (Amvuttra) · ATTR-CM
“FDA scheduled an Advisory Committee for vutrisiran ATTR-CM sBLA on 2026-06-27.”